Philogen Stock Quote PHIL - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

19.15

Bid

19.15

Ask

19.20

Volume

1,140

19.00 Day's Range 19.15

16.30 52 Week Range 21.90

Market Cap

773.614M

Previous Close

19.20

Open

19.00

Last Trade

19.15

Last Trade Time

03:36:21

Financial Volume

VWAP

Average Volume (3m)

4,963

Shares Outstanding

40,397,605

Dividend Yield

PE Ratio

0.00

Earnings Per Share (EPS)

Revenue

25.12M

Net Profit

-6.16M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.philogen.com

Headquarters

Siena, Siena, Ita

Founded

Philogen Spa is listed in the Pharmaceutical Preparations sector of the Italian Stock Exchange with ticker PHIL. The last closing price for Philogen was 19.20 €. Over the last year, Philogen shares have traded in a share price range of 16.30 € to 21.90 €.

Philogen currently has 40,397,605 shares outstanding. The market capitalization of Philogen is 775.63 € million.

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue...

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities SIENA, Italy, Dec. 05, 2023...

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors Novel...

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma

Intratumoral Nidlegy™ followed by surgery significantly improved the Recurrence-Free Survival compared to surgery alone PIVOTAL (NCT02938299) is the first and so far only Phase III trial...

Philogen Announces Clinical Trial Collaboration with MSD

Philogen Announces Clinical Trial Collaboration with MSD The Phase II clinical trial investigates Philogen's immunocytokines (i) L19IL2 (ii) L19TNF, and (iii) Nidlegy™ in combination with...

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand Mumbai...

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich Philogen Publishes New Data on a...

Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical Library Technology

Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical Library Technology Philogen Announces Publication...

Philogen Provides Corporate Update

Philogen Provides Corporate Update Philogen Provides Corporate Update Nidlegy™ and Fibromun pivotal clinical trials on track Fibromun shows potent activity in last-line glioblastoma in...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.25	1.32275132275	18.9	19.3	18.9	3488	19.1	DE
4	0	0	19.15	19.75	18.05	5445	18.80701029	DE
12	-0.55	-2.79187817259	19.7	21.3	18.05	4963	19.52516438	DE
26	-0.85	-4.25	20	21.9	18.05	6574	20.07296869	DE
52	0.5	2.68096514745	18.65	21.9	16.3	8712	19.04397182	DE
156	4.73	32.8016643551	14.42	21.9	13	8781	16.81113105	DE
260	2.15	12.6470588235	17	21.9	12.6	12128	16.01964201	DE

PHIL - Frequently Asked Questions (FAQ)

What is the current Philogen share price?

The current share price of Philogen is 19.15 €

How many Philogen shares are in issue?

Philogen has 40,397,605 shares in issue

What is the market cap of Philogen?

The market capitalisation of Philogen is EUR 775.63M

What is the 1 year trading range for Philogen share price?

Philogen has traded in the range of 16.30 € to 21.90 € during the past year

What is the reporting currency for Philogen?

Philogen reports financial results in EUR

What is the latest annual turnover for Philogen?

The latest annual turnover of Philogen is EUR 25.12M

What is the latest annual profit for Philogen?

The latest annual profit of Philogen is EUR -6.16M

What is the registered address of Philogen?

The registered address for Philogen is PIAZZA LA LIZZA, 7, SIENA, SIENA, 53100

What is the Philogen website address?

The website address for Philogen is www.philogen.com

Which industry sector does Philogen operate in?

Philogen operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
1BYNDBeyond Meat Inc	3.885 € (11.96%)	1.2k
U24Ucapital24 Spa	0.668 € (9.51%)	86.4k
MNLMonnalisa SPA	1.60 € (8.84%)	79.25k
DOXDoxee SpA	1.74 € (8.75%)	7.5k
ENYEnergy Spa	0.988 € (7.39%)	67.5k
FDAFidia	0.0416 € (-7.56%)	839.22k
POZPozzi Milano Spa	0.424 € (-5.78%)	25k
GSRG Rent	0.43 € (-4.44%)	6.5k
PREPredict SpA	0.67 € (-4.01%)	3k
GTGT Talent Group SpA	3.12 € (-3.70%)	1.13k
TITTelecom Italia SpA	0.2462 € (0.12%)	18.8M
TITRTelecom Italia	0.2905 € (0.41%)	4.63M
ISPIntesa Sanpaolo Spa	3.862 € (-0.08%)	3.82M
SPMSaipem Spa	2.491 € (-0.80%)	2.46M
ENELEnel Spa	6.867 € (0.29%)	1.53M